ELAN
Price
$8.44
Change
+$0.34 (+4.20%)
Updated
Apr 17 closing price
Capitalization
7.87B
18 days until earnings call
ZTS
Price
$148.67
Change
+$1.91 (+1.30%)
Updated
Apr 17 closing price
Capitalization
77.48B
17 days until earnings call
Ad is loading...

ELAN vs ZTS

Header iconELAN vs ZTS Comparison
Open Charts ELAN vs ZTSBanner chart's image
Elanco Animal Health
Price$8.44
Change+$0.34 (+4.20%)
Volume$5.41M
Capitalization7.87B
ZOETIS
Price$148.67
Change+$1.91 (+1.30%)
Volume$4.24M
Capitalization77.48B
ELAN vs ZTS Comparison Chart
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. ZTS commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and ZTS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (ELAN: $8.44 vs. ZTS: $148.67)
Brand notoriety: ELAN and ZTS are both notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELAN: 106% vs. ZTS: 128%
Market capitalization -- ELAN: $7.87B vs. ZTS: $77.48B
ELAN [@Pharmaceuticals: Other] is valued at $7.87B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, ZTS is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 3 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 3 bullish, 4 bearish.
  • ZTS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Other) experienced а -3.10% price change this week, while ZTS (@Pharmaceuticals: Other) price change was +1.14% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.78%. For the same industry, the average monthly price growth was -5.82%, and the average quarterly price growth was -13.07%.

Reported Earning Dates

ELAN is expected to report earnings on Aug 11, 2025.

ZTS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.78% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than ELAN($7.87B). ZTS YTD gains are higher at: -8.476 vs. ELAN (-30.306). ZTS has higher annual earnings (EBITDA): 3.67B vs. ELAN (-224M). ZTS has more cash in the bank: 2.04B vs. ELAN (352M). ELAN has less debt than ZTS: ELAN (5.77B) vs ZTS (6.76B). ZTS has higher revenues than ELAN: ZTS (8.54B) vs ELAN (4.42B).
ELANZTSELAN / ZTS
Capitalization7.87B77.5B10%
EBITDA-224M3.67B-6%
Gain YTD-30.306-8.476358%
P/E RatioN/A32.94-
Revenue4.42B8.54B52%
Total Cash352M2.04B17%
Total Debt5.77B6.76B85%
FUNDAMENTALS RATINGS
ELAN vs ZTS: Fundamental Ratings
ELAN
ZTS
OUTLOOK RATING
1..100
6078
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
10062
SMR RATING
1..100
8319
PRICE GROWTH RATING
1..100
8861
P/E GROWTH RATING
1..100
9655
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZTS's Valuation (71) in the Pharmaceuticals Generic industry is in the same range as ELAN (86) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew similarly to ELAN’s over the last 12 months.

ZTS's Profit vs Risk Rating (62) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew somewhat faster than ELAN’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ELAN (83) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew somewhat faster than ELAN’s over the last 12 months.

ZTS's Price Growth Rating (61) in the Pharmaceuticals Generic industry is in the same range as ELAN (88) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew similarly to ELAN’s over the last 12 months.

ZTS's P/E Growth Rating (55) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ELAN (96) in the Agricultural Commodities Or Milling industry. This means that ZTS’s stock grew somewhat faster than ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANZTS
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
58%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
62%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
55%
MACD
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
57%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
58%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
72%
Aroon
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Ad is loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

ELAN and

Correlation & Price change

A.I.dvisor tells us that ELAN and PCRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAN and PCRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+4.20%
PCRX - ELAN
32%
Poorly correlated
+0.74%
VTRS - ELAN
29%
Poorly correlated
+2.30%
AMRX - ELAN
28%
Poorly correlated
+2.51%
PAHC - ELAN
28%
Poorly correlated
+2.73%
ZTS - ELAN
28%
Poorly correlated
+1.30%
More

ZTS and

Correlation & Price change

A.I.dvisor tells us that ZTS and VTRS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZTS and VTRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+1.30%
VTRS - ZTS
33%
Poorly correlated
+2.30%
HLN - ZTS
32%
Poorly correlated
+0.59%
BJTRF - ZTS
31%
Poorly correlated
N/A
EBS - ZTS
30%
Poorly correlated
N/A
AMRX - ZTS
30%
Poorly correlated
+2.51%
More